Xtant Medical Holdings's net income is $-11M, below the Healthcare sector average of $16B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Loading...
Loading...
The latest net income for XTNT is $-11M as of June 2026. That compares with $-4.6M in the prior-year period — down 143.1% year over year. That is below the Healthcare sector average of $16B. Investors often review this figure alongside Xtant Medical Holdings's historical trend and sector peers before judging valuation or financial health.
Over the past year, XTNT's net income moved from $-4.6M to $-11M — a 143.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Xtant Medical Holdings's operating scale or balance-sheet position.
Against Healthcare companies, XTNT currently prints $-11M for net income, while the sector average sits near $16B. That is roughly 100.1% below the sector mean. Large gaps often invite a closer look at Xtant Medical Holdings's growth, margins, and balance sheet.
A net income figure of $-11M for XTNT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $16B. Explore the charts below for those layers of context.
After noting XTNT's net income ($-11M), review year-over-year change from $-4.6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.